2m 2m 2m 2m 2m 2m 2m
TEVOGEN BIO (TVGN)
NASDAQ
$9.00+$0.53 (+6.27%)
Price as of Jun 03, 2026 7:02 PM EDT- $33.1MMarket Cap
- -86.77%1-Year Change
- BiotechnologyIndustry
TEVOGEN BIO (TVGN)
$9.00+$0.53 (+6.27%)
TVGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.47 | ||
Change | +$0.42 (+5.22%) | ||
Open | $8.00 | ||
High | $8.85 | ||
Low | $7.63 | ||
Previous Close | $8.05 | ||
Volume | 19,144 | ||
30-Day Average Volume | 37,044 | ||
1-Week Change | -1.51% | ||
1-Month Change | 27.18% | ||
1-Year Change | -86.77% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $4.9M | ||
Market Cap | $33.1M | ||
Enterprise Value | $34.1M | ||
Period: QTR TTM FY | |||
Revenue | -$71,166.00 | ||
Net Income | -$5.6M | ||
Free Cash Flow | -$2.7M | ||
EBIT | -$5.6M | ||
EBITDA | -$5.5M | ||
Net Working Capital | -$5.1M | ||
EPS | -$1.61 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | -479 | ||
P/B | N/A | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 03/06/2026 | ||
Earnings & Revenue